COHEN LAWRENCE B - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
COHEN LAWRENCE B ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,581,540
+2.3%
25,344
+1.3%
1.74%
+7.8%
Q2 2023$2,524,163
+9.2%
25,014
-0.5%
1.62%
+4.1%
Q1 2023$2,312,144
+6.0%
25,132
+4.5%
1.55%
+36.1%
Q4 2022$2,180,818
+21.3%
24,039
+1.6%
1.14%
-17.7%
Q3 2022$1,798,000
-13.2%
23,659
-3.5%
1.39%
-6.1%
Q2 2022$2,072,000
-8.1%
24,516
-4.5%
1.48%
+10.5%
Q1 2022$2,254,000
-0.2%
25,683
-0.6%
1.34%
+51.5%
Q4 2021$2,259,000
-4.2%
25,827
-10.4%
0.88%
-29.0%
Q3 2021$2,357,000
-14.7%
28,822
-4.8%
1.24%
-11.8%
Q2 2021$2,762,000
+7.6%
30,281
+0.8%
1.41%
+1.2%
Q1 2021$2,568,000
-10.5%
30,049
-1.1%
1.39%
-12.6%
Q4 2020$2,868,000
+9.5%
30,369
+0.8%
1.59%
+0.1%
Q3 2020$2,619,000
-0.3%
30,127
+0.2%
1.59%
-9.2%
Q2 2020$2,626,000
+5.6%
30,065
-0.3%
1.75%
-10.1%
Q1 2020$2,486,000
-9.8%
30,156
+3.6%
1.95%
+19.9%
Q4 2019$2,756,000
+10.6%
29,106
+1.6%
1.63%
-0.2%
Q3 2019$2,491,000
-7.0%
28,658
-2.3%
1.63%
-12.0%
Q2 2019$2,678,000
-6.6%
29,331
-1.7%
1.85%
-8.2%
Q1 2019$2,867,000
+11.9%
29,826
-0.1%
2.02%
+1.4%
Q4 2018$2,563,000
+0.7%
29,870
+1.1%
1.99%
+15.1%
Q3 2018$2,546,000
+16.0%
29,545
+1.7%
1.73%
+10.2%
Q2 2018$2,194,000
-12.0%
29,045
-5.8%
1.57%
-6.2%
Q1 2018$2,494,000
+1.3%
30,845
+5.1%
1.67%
+7.1%
Q4 2017$2,463,000
-0.3%
29,340
+1.9%
1.56%
-2.9%
Q3 2017$2,470,000
+11.1%
28,781
+8.0%
1.61%
+13.2%
Q2 2017$2,224,000
+16.1%
26,643
+3.3%
1.42%
+20.5%
Q1 2017$1,915,000
+19.5%
25,788
+17.2%
1.18%
+21.3%
Q4 2016$1,603,000
+105.5%
22,008
+122.8%
0.97%
+109.7%
Q3 2016$780,000
+48.6%
9,878
+55.1%
0.46%
+47.8%
Q2 2016$525,000
+16.9%
6,368
+2.7%
0.31%
+6.8%
Q1 2016$449,000
-10.7%
6,198
+6.2%
0.29%
-14.0%
Q4 2015$503,000
-4.6%
5,838
+1.7%
0.34%
-6.8%
Q3 2015$527,000
-6.6%
5,7380.0%0.37%
+3.1%
Q2 2015$564,000
-0.4%
5,7380.0%0.36%
+3.2%
Q1 2015$566,000
+4.0%
5,738
-2.4%
0.34%
+5.5%
Q4 2014$544,000
+38.4%
5,878
+40.7%
0.33%
+26.3%
Q3 2014$393,000
+3.1%
4,178
-0.8%
0.26%
+3.6%
Q2 2014$381,000
+6.4%
4,2110.0%0.25%
+1.2%
Q1 2014$358,000
-0.6%
4,211
-6.0%
0.25%
-3.5%
Q4 2013$360,000
+4.7%
4,4780.0%0.26%
-1.5%
Q3 2013$344,000
+19.4%
4,478
+9.8%
0.26%
+22.1%
Q2 2013$288,0004,0780.21%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders